New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 22, 2014
07:08 EDTRXIIRXi Pharmaceuticals granted US Notice of Allowance for technology platform
RXi Pharmaceuticals received the Notice of Allowance from the USPTO on its novel, self-delivering RNAi platform. The patent broadly covers both the composition and methods of use of RXi's self-delivering platform technology. The patent, once issued, will be scheduled to expire in 2029.
News For RXII From The Last 14 Days
Check below for free stories on RXII the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 30, 2014
07:15 EDTRXIIRXi Pharmaceuticals initiates third Phase 2a study for hypertrophic scars
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use